Pacira | PCRX - 贸易债权人

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.09B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	贸易债权人	更改		日
Assertio Holdings	USD 14.66M		3.81M	2025-09
Astellas Pharma	JPY 199.75B		17.8B	2026-03
Bristol-Myers Squibb	USD 4.23B		659M	2026-03
Cara Therapeutics	USD 3.22M		859K	2025-12
Coherus Biosciences	USD 9.91M		14.98M	2025-12
Heron Therapeutics	USD 8.97M		24K	2026-03
Ironwood Pharmaceuticals	USD 3.24M		339K	2026-03
J&J	USD 10.46B		1.53B	2026-03
Ligand Pharmaceuticals	USD 37.11M		33.87M	2026-03
Nektar Therapeutics	USD 10.77M		4.79M	2025-12
Novo Nordisk	DKK 14.8B		4.96B	2026-03
Omeros	USD 8.84M		4.42M	2025-06
Pacira	USD 14.01M		1.14M	2026-03
Perrigo	USD 434.8M		39.7M	2026-03
Pfizer	USD 4.51B		734M	2026-03
Supernus Pharmaceuticals	USD 10.17M		97.63M	2026-03
Teva Pharmaceutical Industries	USD 2.6B		65M	2026-03
Xeris Pharmaceuticals	USD 11.47M		8.39M	2026-03
Xoma	USD 2.65M		1.52M	2025-09
Zoetis	USD 507M		20M	2026-03